Bristol-Myers Squibb CEO and key executive team

• Pamela Fisher

  Vice President, Chief Diversity and Inclusion Officer
• Cari Gallman

  Chief Compliance and Ethics Officer
• Samit Hirawat

  Executive Vice President, Chief Medical Officer, Global Drug Development
• Ann M. Powell

  Executive Vice President, Chief Human Resources Officer
• John L. Damonti

  President, Bristol Myers Squibb Foundation and VP, Patient Assistance
• David Elkins

  Executive Vice President and Chief Financial Officer
• Chris Boerner

  Executive Vice President, Chief Commercialization Officer
• Sandra Leung

  Executive Vice President, General Counsel
• Rupert Vessey

  Executive Vice President and President, Research and Early Development
• Michelle Weese

  Executive Vice President, Corporate Affairs
• Jie D'Elia

  SVP, Oncology, Hematology, and Cell Therapy Business Development
• Emma Lees

  Senior Vice President, Research and Early Development. Head, Mechanisms of Cancer Resistance TRC
• Sandro Imbesi

  Regulatory Science Director
• Antonella Iacovelli

  Head of Corporate Affairs, Italy
• Robert Plenge

  SVP and Head, Immunology, Cardiovascular and Fibrosis Thematic Research Center; Head, Translational Medicine
• Estelle Vester-Blokland

  Senior Vice President, Global Medical Affairs
• Kristen M. Hege

  SVP, Early Clinical Development, Oncology/Hematology and Cell Therapy
• Mark Rolfe

  SVP, Oncogenesis Thematic Research Center
• Ho Cho

  Senior Vice President
• Janeen Doyle

  Senior Vice President, Global Alliances
• Martin Crook

  VP, Oncology and Hematology Search & Evaluation
• Joseph Szustakowski

  VP, Translational Bioinformatics
• Erica Horwitz

  Vice President, M&A
• Michael May

  Vice President, Medical Director Germany
• Konstantina Katcheves

  SVP, Innovative Technologies Business Development and Geographic Search
• Myrtle Davis

  Executive Director, Discovery Toxicology
• David Gordon

  VP, Cardiovascular and Fibrosis Discovery Biology
• Binodh Desilva

  VP, Lead, Discovery and Optimization, Small Molecule Drug Discovery
• Beatrice Anduze-Faris

  VP, Global Clinical Compliance & Continuous Improvement (GCC&CI), Global Development Operations
• Tim Power

  Vice President, Head of Investor Relations
• Tunde Bello

  Vice President, Clinical Pharmacology and Pharmacometrics
• Melissa Harris

  Vice President and Head of Fibrosis Development
• Anna Rivkin

  VP, Cardiovascular, Fibrosis, Immunology and Neuroscience Business Development
• Sharon Cload

  Vice President, Discovery Biotherapeutics, East Coast
• John Fortin

  Executive Director, Manufacturing, Cell and Gene Therapy Technologies
• Brian Cook

  Executive Director, Business Development, Oncology Transactions
• Michael McInerney

  Executive Director, Digital Health Business Development
• Elizabeth A. Mily

  Executive Vice President, Strategy & Business Development
• Jay Foust

  Executive Director, Translational Medicine Business Development
• Cosimo Paga

  Executive Director Major Market Medical Team, Italy
• Michele Deblasio

  Executive Director, Global Alliances
• Samantha Good

  Vice President, Global Alliances
• Robert Merriman

  Executive Director, Corporate Development Transactions
• Michael Cucolo

  Executive Director, Research and Enabling Transactions
• Fang Zhang

  Executive Director, China Business Development
• Priya Sriraman

  Executive Director, Global Alliances
• Elinora Pisanti

  Director, HR Italy
• Alessio Battaglia

  Strategy, Innovation and Business Operations Director, Italy
• Theodore R. Samuels

  Lead Independent Director
• José Alberto Cerutti

  Senior Corporate Counsel - Head of Legal & Compliance

Source: bms.com, bms.com, bms.com, bms.com, bms.com, bms.com, news.bms.com, bms.com